6MW-80143-75337
2 vaccinations
5 coded responses
23 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 787 / TX
- Registered
- 2021-01-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Registered in v-safe
-
2021-01-30
Dose 1 — Pfizer-BioNTech
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
-
2021-02-25
Dose 2 — Pfizer-BioNTech
- 2021-02-27
- 2021-02-28
- 2021-03-01
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-03
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Fair · Fatigue or tirednessFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-27
- 2021-04-03
- 2021-04-08
-
2021-05-27
Survey response — 3 months, dose 2MedDRA: Brain fog, Fatigue — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Fatigue and brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-26
Survey response — 6 months, dose 2MedDRA: Dizziness — Feeling: GoodFree text: DizzinessMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2022-02-25
Survey response — 12 months, dose 2MedDRA: Tinnitus — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: TinnitusMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-28
- 2022-03-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-25 | Unsuccessful |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog
Release 8 — 3 months, dose 2
Symptoms: Fatigue and brain fog
Release 9 — 6 months, dose 2
Symptoms: Dizziness
Release 11 — 12 months, dose 2
Symptoms: Tinnitus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | ✓ | ✓ | ✓ |
| SD | Dizziness | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release